Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 1423053 MIAMI, FL
Back to SPRY Full portfolio

Position in SPRY

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$4,253,814
-$9,984,885 QoQ
Shares Held
531,063
-70.1% QoQ
Ownership
0.534%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 208 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Derivatives in SPRY

reported options exposure · as of Jun 30, 2026
CallValue
$165,006
CallShares
20,600
PutValue
$119,349
PutShares
14,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. SPRY ranks #148 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in SPRY

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,253,814 531,063
2026-06-30 $119,349 14,900
2026-06-30 $165,006 20,600
2026-03-31 $417,560 52,000
2026-03-31 $118,041 14,700
2026-03-31 $14,238,699 1,773,188
2025-12-31 $22,769,597 1,954,472
2025-12-31 $810,840 69,600
2025-12-31 $195,720 16,800
2025-09-30 $1,289,415 128,300
2025-09-30 $148,740 14,800
2025-09-30 $15,939,630 1,586,033
2025-06-30 $1,722,315 98,700
2025-06-30 $315,845 18,100
2025-06-30 $39,125,971 2,242,176
2025-03-31 $1,793,908 142,600
2025-03-31 $363,562 28,900
2025-03-31 $10,080,227 801,290
2024-12-31 $2,431,775 230,500
2024-12-31 $123,435 11,700
2024-12-31 $8,497,559 805,456
2024-09-30 $2,337,400 161,200
2024-09-30 $37,700 2,600
2024-09-30 $3,661,235 252,499
2024-06-30 $772,350 90,758
2024-06-30 $171,051 20,100
2024-06-30 $427,202 50,200
2024-03-31 $429,240 42,000
2024-03-31 $257,544 25,200
2024-03-31 $1,145,304 112,065
2023-12-31 $175,360 32,000
2023-12-31 $299,756 54,700
2023-12-31 $174,280 31,803
2023-09-30 $43,613 11,538
2023-09-30 $185,598 49,100
2023-09-30 $436,968 115,600
2023-06-30 $1,476,331 220,348
2023-06-30 $155,440 23,200
2023-06-30 $268,000 40,000
2023-03-31 $14,322 2,200
2023-03-31 $244,776 37,600
2023-03-31 $291,491 44,776
2022-12-31 $337,788 39,600
2022-12-31 $70,772 8,297
2022-09-30 $64,416 12,200
2022-09-30 $514,641 97,470
2022-06-30 $259,912 61,300
2022-06-30 $982,263 231,666
2022-06-30 $373,120 88,000
2022-03-31 $684,997 195,156